Bird & Bird advises Keolis on German market exit

Bird & Bird has advised French Keolis S.A. on its market exit from the German local passenger rail transport (SPNV) business. Keolis S.A. is a subsidiary of the French national railway SNCF and the pension and insurance fund of Quebec Caisse de dépôt et placement du Québec (CDPQ). 

From 1st January 2022, the Noerr subsidiary TEAM Treuhand GmbH will acquire the shares of Keolis S.A. via a subsidiary in the form of a UG (limited liability) and will become the new shareholder of Keolis Deutschland GmbH & Co. KG, as well as its general partner. The well-known brand name eurobahn becomes the company name, and Keolis Deutschland GmbH & Co. KG becomes eurobahn GmbH & Co. KG. 

Keolis Deutschland, Keolis SA. and the public transport authorities Nahverkehr Westfalen-Lippe (NWL), Verkehrsverbund Rhein Ruhr (VRR), Landesnahverkehrsgesellschaft Niedersachsen (LNVG) and Provincie Overijssel have also agreed on the reorganisation of the existing transport contracts. 
Keolis Deutschland's operations will continue unchanged.

The parties have agreed not to disclose the financial details of the transaction.

Keolis S.A. was advised by an interdisciplinary team with the following Bird & Bird lawyers: senior Counsel Dr Kathrin Knöfler (Corporate/M&A), partner Dr Jan Byok, LL.M. (Public Procurement Law), both lead; partner Dr Stefan Gottgetreu, associates Benita Schild and Dominic Poster (both Corporate/M&A); associates Anna Horschik and Mario Kreutzer (both Public Procurement Law); partner Dr Jörg Witting, associate Tamy Tietze (Competition Law), all Düsseldorf.

News & Deals

More News & Deals

Deal

Bird & Bird advises World of Women on its transaction to join the Tezos ecosystem

Jul 23 2024

Read More

Deal

Bird & Bird advised EIFFEL GAZ VERT on an investment in the biogas sector

Jul 23 2024

Read More

News

Bird & Bird grows its Finance practice in Italy with the arrival of two new partners

Jul 19 2024

Read More

Deal

Bird & Bird has advised Dopay on its $13.5 million Series A Extension round

Jul 19 2024

Read More

News

Bird & Bird advises iX Biopharma on rights issue

Jul 15 2024

Read More

Deal

Bird & Bird advises HSS on SciRhom’s EUR 63 million Series A financing round

Jul 11 2024

Read More